VBIV
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
VBIV
Delisted
VBIV was delisted on the 7th of August, 2024.
127 hedge funds and large institutions have $69.9M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2022 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 30 increasing their positions, 50 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
40% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 50
Holders
127
Holding in Top 10
–
Calls
$382K
Puts
$65K
Top Buyers
| 1 | +$635K | |
| 2 | +$447K | |
| 3 | +$425K | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$137K |
| 5 |
WAAG
Wealth Alliance Advisory Group
Wichita,
Kansas
|
+$128K |
Top Sellers
| 1 | -$1.24M | |
| 2 | -$641K | |
| 3 | -$466K | |
| 4 |
E
Ergoteles
New York
|
-$349K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$318K |